Jun 15, 2022 / Chapters Chapter 7: Segmentation in the stand-alone Part D plan market (June 2022 report) Research Areas: Beneficiaries and Coverage, Drugs, Devices, and Tests
Jun 15, 2022 / Chapters Appendix A: Commissioners’ voting on recommendations (June 2022 report) Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Private Plans, Quality, Regional Issues
Jun 15, 2022 / Press Releases MedPAC releases June 2022 Report to the Congress: Medicare and the Health Care Delivery System Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Private Plans, Quality, Regional Issues
Apr 07, 2022 / Presentations Segmentation in the stand-alone Part D prescription drug plan market Research Areas: Drugs, Devices, and Tests
Apr 07, 2022 / Presentations Initial findings from MedPAC’s analysis of Part D data on drug rebates and discounts Research Areas: Drugs, Devices, and Tests
Apr 07, 2022 / Transcripts April 2022 meeting transcript Research Areas: Ambulatory Care Settings, Drugs, Devices, and Tests, Medicare Spending and Financing, Quality
Mar 15, 2022 / Press Releases MedPAC releases March 2022 Report to the Congress: Medicare Payment Policy Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues
Mar 15, 2022 / Reports March 2022 Report to the Congress: Medicare Payment Policy Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues
Mar 15, 2022 / Chapters Executive Summary (March 2022 Report) Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues
Mar 15, 2022 / Chapters Chapter 13: The Medicare prescription drug program (Part D): Status report (March 2022 Report) Research Areas: Drugs, Devices, and Tests, Quality